Figures computed from official regulatory filings — .
Analysttarget 15 USD (+101%) · consensus 5/5 · 1 buy · 0 hold · 0 sell
Ownershipinsiders 59.09% · institutions 2.9% · short 3.4% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for NutriBand Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
3 buysbar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Sheridan Gareth | AwardD (derivative) | $236.7K | SEC | ||
| Sheridan Gareth |
| AwardD (derivative) |
| $254.5K |
| SEC |
| Goodman Gerald | OtherD (derivative) | $116K | SEC |
| Goodman Gerald | AwardD (derivative) | $144.8K | SEC |
| Goodman Gerald | AwardD (derivative) | $129.7K | SEC |
| Goodman Gerald | Other | $116K | SEC |
| Goodman Gerald | AwardD (derivative) | $177.8K | SEC |
| Goodman Gerald | ExerciseD (derivative) | $168.9K | SEC |
| Sheridan Gareth | AwardD (derivative) | $177.8K | SEC |
| MELNIK SERGUEI | AwardD (derivative) | $254.5K | SEC |
| Goodman Gerald | AwardD (derivative) | $95.4K | SEC |
| Goodman Gerald | AwardD (derivative) | $70.6K | SEC |
| Goodman Gerald | Award | n/a (No price was disclosed in the filing) | SEC |
| Goodman Gerald | AwardD (derivative) | $95.5K | SEC |
| Goodman Gerald | AwardD (derivative) | $46.5K | SEC |
| Goodman Gerald | AwardD (derivative) | $168.9K | SEC |
| MELNIK SERGUEI | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| MELNIK SERGUEI | AwardD (derivative) | $106.9K | SEC |
| Sheridan Gareth | AwardD (derivative) | $106.9K | SEC |
| Sheridan Gareth | Award | $38K | SEC |
| Sheridan Gareth | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| MELNIK SERGUEI | AwardD (derivative) | $106.8K | SEC |
| MELNIK SERGUEI | Buy | $2K | conv 36First in 12mo | SEC |
| MELNIK SERGUEI | Buy | $20.2K | conv 57First in 12mo | SEC |
| MELNIK SERGUEI | Buy | $2K | conv 57First in 12mo | SEC |